SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study.
Oliver T StirrupFlorencia BoshierCristina VenturiniJosé Afonso Guerra-AssunçãoAdela Alcolea-MedinaAngela BeckettThemoula CharalampousAna da Silva FilipeSharon GlaysherTabassum KhanRaghavendran Kulasegaran ShyliniBeatrix KeleIrene MonahanGuy MollettMatthew ParkerEmanuela PelosiPaul RandellSunando RoyJoshua TaylorSophie WellerEleri Wilson-DaviesPhillip WadeRachel Williamsnull nullnull nullAndrew CopasMaria-Teresa Cutino-MoguelNick FreemantleAndrew C HaywardAlison HolmesJoseph HughesTabitha MahunguGaia NebbiaDavid PartridgeCassie PopeJames R PriceSamuel RobsonKordo SaeedThushan de SilvaLuke SnellEmma ThomsonAdam A WitneyJudith BreuerPublished in: BMJ open respiratory research (2021)
In common with smaller studies of patients hospitalised with SARS-CoV-2, we did not find an overall increase in mortality or ITU admission associated with B.1.1.7 compared with other lineages. However, women with B.1.1.7 may be at an increased risk of admission to intensive care and at modestly increased risk of mortality.
Keyphrases
- sars cov
- end stage renal disease
- emergency department
- cardiovascular events
- respiratory syndrome coronavirus
- newly diagnosed
- ejection fraction
- chronic kidney disease
- clinical trial
- risk factors
- peritoneal dialysis
- study protocol
- community acquired pneumonia
- cardiovascular disease
- cross sectional
- patient reported outcomes
- middle aged
- coronavirus disease
- skeletal muscle
- double blind
- pregnancy outcomes
- cell fate